HedgeChatter

  • Home /
  • Tag Archives

SRPT

SHAREHOLDER ALERT: Pomerantz Law Firm has filed a Class Action Against Sarepta Therapeutics, Inc. and Certain Officers – SRPT

[PR Newswire] – NEW YORK, Feb. 28, 2014 /PRNewswire/ — Pomerantz LLP has filed a class action lawsuit against Sarepta Therapeutics, Inc. (Sarepta or the Company) (SRPT) and certain of its officers. The class action, filed in United States District Court moreView todays social media effects on SRPTView the latest stocks trending across Twitter. Click to view dashboardSee who Sarepta […]

February 28, 2014 Bystocknews , Comments Off on SHAREHOLDER ALERT: Pomerantz Law Firm has filed a Class Action Against Sarepta Therapeutics, Inc. and Certain Officers – SRPT read more

Sarepta Therapeutics’ CEO Discusses Q4 2013 Results – Earnings Call Transcript

[at Seeking Alpha] – Chris Garabedian Thank you, Erin. Good morning everyone and thank you for joining us today for our financial and corporate update for the fourth quarter and full-year of 2013. moreView todays social media effects on SRPTView the latest stocks trending across Twitter. Click to view dashboardSee who Sarepta is hiring next, click here to view […]

February 27, 2014 Bystocknews , Comments Off on Sarepta Therapeutics’ CEO Discusses Q4 2013 Results – Earnings Call Transcript read more

Sarepta Therapeutics Announces Fourth Quarter and Full Year 2013 Financial Results and Recent Corporate Developments

[at noodls] – Clarity on Eteplirsen Confirmatory Trial Design Expected in Coming Weeks 2014 Financial Guidance of $110-120 Million in Non-GAAP Operating Loss Cash and Other Investments of $265 Million at Year End 2013 … moreView todays social media effects on SRPTView the latest stocks trending across Twitter. Click to view dashboardSee who Sarepta is hiring next, click here to […]

February 27, 2014 Bystocknews , Comments Off on Sarepta Therapeutics Announces Fourth Quarter and Full Year 2013 Financial Results and Recent Corporate Developments read more